뉴스
Recursion Pharmaceuticals is a leader in TechBio with potential to bring in $200M in near-term milestones and $20B in future revenue, according to Needham.
Recursion releases open-source data from largest ever dataset of biological images and a machine learning competition available through NeurIPS 2019.
사용자가 액세스할 수 없을 수 있는 결과가 현재 표시되고 있습니다.
액세스할 수 없는 결과 숨기기
피드백